abstract |
The present invention discloses a compound represented by formula I, its pharmaceutically acceptable salt, stereoisomer, solvate or prodrug, wherein each symbol is as defined in the claims. The compound represented by formula I of the present invention has good inhibitory activity on ALK kinase, and can be used to prepare drugs for regulating ALK kinase activity or treating ALK-related diseases, especially non-small cell lung cancer. |